HomeCompareRMES vs JNJ

RMES vs JNJ: Dividend Comparison 2026

RMES yields 1000.00% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 RMES wins by $18844438.65M in total portfolio value
10 years
RMES
RMES
● Live price
1000.00%
Share price
$0.20
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$18844438.68M
Annual income
$15,746,803,993,532.36
Full RMES calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — RMES vs JNJ

📍 RMES pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRMESJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RMES + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RMES pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RMES
Annual income on $10K today (after 15% tax)
$85,000.00/yr
After 10yr DRIP, annual income (after tax)
$13,384,783,394,502.51/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, RMES beats the other by $13,384,783,390,516.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RMES + JNJ for your $10,000?

RMES: 50%JNJ: 50%
100% JNJ50/50100% RMES
Portfolio after 10yr
$9422219.35M
Annual income
$7,873,401,999,110.88/yr
Blended yield
83.56%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

RMES
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RMES buys
0
JNJ buys
0
No recent congressional trades found for RMES or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRMESJNJ
Forward yield1000.00%2.13%
Annual dividend / share$2.00$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%28%
Portfolio after 10y$18844438.68M$30.3K
Annual income after 10y$15,746,803,993,532.36$4,689.40
Total dividends collected$18607754.73M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RMES vs JNJ ($10,000, DRIP)

YearRMES PortfolioRMES Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$110,700$100,000.00$10,592$272.30+$100.1KRMES
2$1,153,028$1,034,579.44$11,289$357.73+$1.14MRMES
3$11,304,737$10,070,996.94$12,123$472.89+$11.29MRMES
4$104,376,400$92,280,331.11$13,141$629.86+$104.36MRMES
5$907,965,307$796,282,558.81$14,408$846.81+$907.95MRMES
6$7,445,190,031$6,473,667,152.78$16,021$1,151.60+$7445.17MRMES
7$57,576,798,154$49,610,444,821.11$18,122$1,588.22+$57576.78MRMES
8$420,166,535,918$358,559,361,892.40$20,930$2,228.20+$420166.51MRMES
9$2,894,985,686,808$2,445,407,493,376.48$24,792$3,191.91+$2894985.66MRMES
10$18,844,438,678,417$15,746,803,993,532.36$30,274$4,689.40+$18844438.65MRMES

RMES vs JNJ: Complete Analysis 2026

RMESStock

Red Metal Resources Ltd., an early stage mineral exploration company, engages in acquiring, exploring, and developing mineral resources in Chile. The company explores for copper, gold, cobalt, and silver deposits. It holds interests in the Farellon property that covers a total area of 1,234 hectares, which is located in the Carrizal Alto mining district; the Perth property, which covers an area of approximately 2,300 hectares that is located in the III Region of Atacama, Chile; and the Mateo property covering an area of 192 hectares in the III Region of Chile, Region de Atacama. The company was formerly known as Red Lake Exploration, Inc. and changed its name to Red Metal Resources Ltd. in August 2008. Red Metal Resources Ltd. was founded in 2005 and is headquartered in Thunder Bay, Canada.

Full RMES Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this RMES vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RMES vs SCHDRMES vs JEPIRMES vs ORMES vs KORMES vs MAINRMES vs ABBVRMES vs MRKRMES vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.